198 related articles for article (PubMed ID: 174379)
1. GM2-gangliosidosis, AB variant: clinico-pathological study of a case.
de Baecque CM; Suzuki K; Rapin I; Johnson AB; Whethers DL
Acta Neuropathol; 1975 Dec; 33(3):207-26. PubMed ID: 174379
[TBL] [Abstract][Full Text] [Related]
2. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.
Kotagal S; Wenger DA; Alcala H; Gomez C; Horenstein S
Neurology; 1986 Mar; 36(3):438-40. PubMed ID: 3081832
[TBL] [Abstract][Full Text] [Related]
3. [The so-called amaurotic idiocies. Clinical, morphological and biochemical findings as a basis for modern classification].
Minauf M
Veroff Pathol; 1975; 96():1-89. PubMed ID: 180723
[TBL] [Abstract][Full Text] [Related]
4. Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship.
Rapin I; Suzuki K; Suzuki K; Valsamis MP
Arch Neurol; 1976 Feb; 33(2):120-30. PubMed ID: 175770
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis).
Fox J; Li YT; Dawson G; Alleman A; Johnsrude J; Schumacher J; Homer B
Acta Neuropathol; 1999 Jan; 97(1):57-62. PubMed ID: 9930895
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
7. The AB-variant of GM2-gangliosidosis. Clinical, biochemical, and pathological studies of two patients.
Goldman JE; Yamanaka T; Rapin I; Adachi M; Suzuki K; Suzuki K
Acta Neuropathol; 1980; 52(3):189-202. PubMed ID: 6255724
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
10. Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay.
Molzer B; Bernheimer H
Clin Chim Acta; 1976 Nov; 73(1):163-9. PubMed ID: 826357
[TBL] [Abstract][Full Text] [Related]
11. Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment.
Liu Y; Hoffmann A; Grinberg A; Westphal H; McDonald MP; Miller KM; Crawley JN; Sandhoff K; Suzuki K; Proia RL
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8138-43. PubMed ID: 9223328
[TBL] [Abstract][Full Text] [Related]
12. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
[TBL] [Abstract][Full Text] [Related]
13. Fine structure of cutaneous nerves in ganglioside storage disease.
Dolman CL; MacLeod PM; Chang E
J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):588-94. PubMed ID: 198513
[TBL] [Abstract][Full Text] [Related]
14. Tay-Sachs disease with conspicuous cranial computerized tomographic appearances.
Watanabe K; Mukawa A; Muto K; Nishikawa J; Takahashi S
Acta Pathol Jpn; 1985 Nov; 35(6):1521-32. PubMed ID: 2936060
[TBL] [Abstract][Full Text] [Related]
15. The gangliosidoses.
Volk BW; Adachi M; Schneck L
Hum Pathol; 1975 Sep; 6(5):555-69. PubMed ID: 170187
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
17. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Conzelmann E; Sandhoff K
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
[TBL] [Abstract][Full Text] [Related]
18. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
Seyrantepe V; Demir SA; Timur ZK; Von Gerichten J; Marsching C; Erdemli E; Oztas E; Takahashi K; Yamaguchi K; Ates N; Dönmez Demir B; Dalkara T; Erich K; Hopf C; Sandhoff R; Miyagi T
Exp Neurol; 2018 Jan; 299(Pt A):26-41. PubMed ID: 28974375
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
Pullarkat RK; Reha H; Beratis NG
Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
Hechtman P; Gordon BA; Ng Ying Kin NM
Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
